The companion animal diagnostics market is characterized by a diverse geographical landscape where regional trends, economic shifts, and pet ownership dynamics dictate market momentum. Valued at US$ 4.61 billion in 2024, the market is on a steady climb to reach US$ 8.80 billion by 2031, progressing at a CAGR of 9.8%. While the core technologies of clinical biochemistry and immunodiagnostics...